Global Viral Vector Development Service Market 2021 by Company, Regions, Type and Application, Forecast to 2026

1 Market Overview

1.1 Product Overview and Scope of Viral Vector Development Service

1.2 Classification of Viral Vector Development Service by Type

1.2.1 Overview: Global Viral Vector Development Service Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Viral Vector Development Service Revenue Market Share by Type in 2020

1.2.3 Retroviral Vectors

1.2.4 Lentiviral Vectors

1.2.5 Adenoviral Vectors

1.2.6 Adeno-associated Viral Vectors

1.2.7 Others Viral Vectors

1.3 Global Viral Vector Development Service Market by Application

1.3.1 Overview: Global Viral Vector Development Service Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical Manufacturers

1.3.3 Biotechnology Companies

1.3.4 Research Institutes

1.4 Global Viral Vector Development Service Market Size & Forecast

1.5 Global Viral Vector Development Service Market Size and Forecast by Region

1.5.1 Global Viral Vector Development Service Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Viral Vector Development Service Market Size by Region, (2016-2021)

1.5.3 North America Viral Vector Development Service Market Size and Prospect (2016-2026)

1.5.4 Europe Viral Vector Development Service Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Viral Vector Development Service Market Size and Prospect (2016-2026)

1.5.6 South America Viral Vector Development Service Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Viral Vector Development Service Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Viral Vector Development Service Market Drivers

1.6.2 Viral Vector Development Service Market Restraints

1.6.3 Viral Vector Development Service Trends Analysis

2 Company Profiles

2.1 UJIFILM Diosynth Biotechnologies

2.1.1 UJIFILM Diosynth Biotechnologies Details

2.1.2 UJIFILM Diosynth Biotechnologies Major Business

2.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Product and Solutions

2.1.4 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 UJIFILM Diosynth Biotechnologies Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Viral Vector Development Service Product and Solutions

2.2.4 Sanofi Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Spark Therapeutics

2.3.1 Spark Therapeutics Details

2.3.2 Spark Therapeutics Major Business

2.3.3 Spark Therapeutics Viral Vector Development Service Product and Solutions

2.3.4 Spark Therapeutics Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Spark Therapeutics Recent Developments and Future Plans

2.4 UniQure

2.4.1 UniQure Details

2.4.2 UniQure Major Business

2.4.3 UniQure Viral Vector Development Service Product and Solutions

2.4.4 UniQure Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 UniQure Recent Developments and Future Plans

2.5 MassBiologics

2.5.1 MassBiologics Details

2.5.2 MassBiologics Major Business

2.5.3 MassBiologics Viral Vector Development Service Product and Solutions

2.5.4 MassBiologics Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 MassBiologics Recent Developments and Future Plans

2.6 FinVector

2.6.1 FinVector Details

2.6.2 FinVector Major Business

2.6.3 FinVector Viral Vector Development Service Product and Solutions

2.6.4 FinVector Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 FinVector Recent Developments and Future Plans

2.7 Thermo Fisher Scientific (Brammer Bio)

2.7.1 Thermo Fisher Scientific (Brammer Bio) Details

2.7.2 Thermo Fisher Scientific (Brammer Bio) Major Business

2.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Product and Solutions

2.7.4 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments and Future Plans

2.8 Cell and Gene Therapy Catapult

2.8.1 Cell and Gene Therapy Catapult Details

2.8.2 Cell and Gene Therapy Catapult Major Business

2.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Product and Solutions

2.8.4 Cell and Gene Therapy Catapult Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans

2.9 Cobra Biologics

2.9.1 Cobra Biologics Details

2.9.2 Cobra Biologics Major Business

2.9.3 Cobra Biologics Viral Vector Development Service Product and Solutions

2.9.4 Cobra Biologics Viral Vector Development Service Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Cobra Biologics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Viral Vector Development Service Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Viral Vector Development Service Players Market Share

3.2.2 Top 10 Viral Vector Development Service Players Market Share

3.2.3 Market Competition Trend

3.3 Viral Vector Development Service Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Viral Vector Development Service Revenue and Market Share by Type (2016-2021)

4.2 Global Viral Vector Development Service Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Viral Vector Development Service Revenue Market Share by Application (2016-2021)

5.2 Viral Vector Development Service Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Viral Vector Development Service Revenue by Type (2016-2026)

6.2 North America Viral Vector Development Service Revenue by Application (2016-2026)

6.3 North America Viral Vector Development Service Market Size by Country

6.3.1 North America Viral Vector Development Service Revenue by Country (2016-2026)

6.3.2 United States Viral Vector Development Service Market Size and Forecast (2016-2026)

6.3.3 Canada Viral Vector Development Service Market Size and Forecast (2016-2026)

6.3.4 Mexico Viral Vector Development Service Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Viral Vector Development Service Revenue by Type (2016-2026)

7.2 Europe Viral Vector Development Service Revenue by Application (2016-2026)

7.3 Europe Viral Vector Development Service Market Size by Country

7.3.1 Europe Viral Vector Development Service Revenue by Country (2016-2026)

7.3.2 Germany Viral Vector Development Service Market Size and Forecast (2016-2026)

7.3.3 France Viral Vector Development Service Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Viral Vector Development Service Market Size and Forecast (2016-2026)

7.3.5 Russia Viral Vector Development Service Market Size and Forecast (2016-2026)

7.3.6 Italy Viral Vector Development Service Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Viral Vector Development Service Revenue by Type (2016-2026)

8.2 Asia-Pacific Viral Vector Development Service Revenue by Application (2016-2026)

8.3 Asia-Pacific Viral Vector Development Service Market Size by Region

8.3.1 Asia-Pacific Viral Vector Development Service Revenue by Region (2016-2026)

8.3.2 China Viral Vector Development Service Market Size and Forecast (2016-2026)

8.3.3 Japan Viral Vector Development Service Market Size and Forecast (2016-2026)

8.3.4 South Korea Viral Vector Development Service Market Size and Forecast (2016-2026)

8.3.5 India Viral Vector Development Service Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Viral Vector Development Service Market Size and Forecast (2016-2026)

8.3.7 Australia Viral Vector Development Service Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Viral Vector Development Service Revenue by Type (2016-2026)

9.2 South America Viral Vector Development Service Revenue by Application (2016-2026)

9.3 South America Viral Vector Development Service Market Size by Country

9.3.1 South America Viral Vector Development Service Revenue by Country (2016-2026)

9.3.2 Brazil Viral Vector Development Service Market Size and Forecast (2016-2026)

9.3.3 Argentina Viral Vector Development Service Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Viral Vector Development Service Revenue by Type (2016-2026)

10.2 Middle East & Africa Viral Vector Development Service Revenue by Application (2016-2026)

10.3 Middle East & Africa Viral Vector Development Service Market Size by Country

10.3.1 Middle East & Africa Viral Vector Development Service Revenue by Country (2016-2026)

10.3.2 Turkey Viral Vector Development Service Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Viral Vector Development Service Market Size and Forecast (2016-2026)

10.3.4 UAE Viral Vector Development Service Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer